Protocol for a definitive randomised controlled trial and economic evaluation of a community-based rehabilitation programme following hip fracture: fracture in the elderly multidisciplinary rehabilitation-phase III (FEMuR III).


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
16 10 2020
Historique:
entrez: 17 10 2020
pubmed: 18 10 2020
medline: 15 5 2021
Statut: epublish

Résumé

Proximal femoral (hip) fracture is common, serious and costly. Rehabilitation may improve functional recovery but evidence of effectiveness and cost-effectiveness are lacking. An enhanced rehabilitation intervention was previously developed and a feasibility study tested the methods used for this randomised controlled trial (RCT). The objectives are to compare the effectiveness and cost-effectiveness of the enhanced rehabilitation programme following surgical repair of proximal femoral fracture in older people compared with usual care. Protocol for phase III, parallel-group, two-armed, superiority, pragmatic RCT with 1:1 allocation ratio; allocation sequence by minimisation programme with a built-in random element; secure web-based allocation concealment. The two treatments will be usual care (control) and usual care plus an enhanced rehabilitation programme (intervention). The enhanced rehabilitation will consist of a patient-held information workbook, goal setting diary and up to six additional therapy sessions. Outcome assessment and statistical analysis will be performed blind; patient and carer participants will be unblinded. Outcomes will be measured at baseline, 17 and 52 weeks' follow-up. Primary outcome at 52 weeks will be the Nottingham Extended Activities of Daily Living scale. Secondary outcomes will measure anxiety and depression, health utility, cognitive status, hip pain intensity, falls self-efficacy, fear of falling, grip strength and physical function. Carer strain, anxiety and depression will be measured in carers. All safety events will be recorded, and serious adverse events will be assessed to determine whether they are related to the intervention and expected. Concurrent economic evaluation will be a cost-utility analysis from a health service and personal social care perspective. An embedded process evaluation will determine the mechanisms and processes that explain the implementation and impacts of the enhanced rehabilitation programme. National Health Service research ethics approval reference 18/NE/0300. Results will be disseminated by peer-reviewed publication. ISRCTN28376407; Pre-results registered on 23 November 2018.

Identifiants

pubmed: 33067298
pii: bmjopen-2020-039791
doi: 10.1136/bmjopen-2020-039791
pmc: PMC7569930
doi:

Banques de données

ISRCTN
['ISRCTN28376407']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e039791

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: NHW reports additional grants from NIHR HS&DR outside the submitted work and membership of the NIHR HTA programme funding committee (commissioned research).

Références

Health Technol Assess. 2009 Aug;13(39):1-143, iii-iv
pubmed: 19712593
Arch Phys Med Rehabil. 2009 Feb;90(2):246-62
pubmed: 19236978
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Age Ageing. 2005 Nov;34(6):614-9
pubmed: 16267188
Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001704
pubmed: 21412873
Pilot Feasibility Stud. 2015 Apr 7;1:13
pubmed: 27965792
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Gerontol. 1983 May;38(3):344-8
pubmed: 6841931
J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
pubmed: 10811152
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD007125
pubmed: 19821396
Injury. 2011 Nov;42(11):1230-3
pubmed: 21183180
Gerontology. 2010;56(2):190-9
pubmed: 19729878
BMJ Open. 2017 Oct 11;7(10):e014362
pubmed: 29025824
BMJ. 2006 Feb 18;332(7538):413-6
pubmed: 16484270
Psychol Rev. 1977 Mar;84(2):191-215
pubmed: 847061
Age Ageing. 1999 May;28(3):283-8
pubmed: 10475865
BMC Med. 2010 Mar 24;8:18
pubmed: 20334633
BMJ Open. 2014 Apr 19;4(4):e004405
pubmed: 24747789
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007624
pubmed: 20091644
Implement Sci. 2007 Nov 30;2:40
pubmed: 18053122
Cochrane Database Syst Rev. 2020 Feb 7;2:CD010569
pubmed: 32031676
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Eur Orthop Traumatol. 2012 Jun;3(2):101-105
pubmed: 22798966
Geriatr Orthop Surg Rehabil. 2010 Sep;1(1):6-14
pubmed: 23569656
Arch Phys Med Rehabil. 2011 Aug;92(8):1281-7
pubmed: 21807147
JAMA. 1999 Feb 10;281(6):558-60
pubmed: 10022113
Phys Ther. 2012 Nov;92(11):1437-51
pubmed: 22822235
Trials. 2013 Jan 12;14:15
pubmed: 23311722
Health Technol Assess. 2017 Aug;21(44):1-528
pubmed: 28836493
Age Ageing. 1972 Nov;1(4):233-8
pubmed: 4669880
Inj Prev. 2011 Dec;17(6):365-70
pubmed: 21486987
BMJ Open. 2018 Aug 8;8(8):e021486
pubmed: 30093516
Physiother Can. 2012 Spring;64(2):190-201
pubmed: 23449813
BMJ Open. 2016 Oct 5;6(10):e012422
pubmed: 27707828
J Am Geriatr Soc. 2010 Sep;58(9):1721-6
pubmed: 20863331
BMJ. 2005 Dec 10;331(7529):1374
pubmed: 16299013
J Eval Clin Pract. 2014 Aug;20(4):445-52
pubmed: 24840165
J Am Geriatr Soc. 2010 Nov;58(11):2228-30
pubmed: 21054305

Auteurs

Nefyn Williams (N)

Department of Primary Care and Mental Health, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK nefyn.williams@liverpool.ac.uk.

Susanna Dodd (S)

Liverpool Clinical Trials Centre, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK.

Ben Hardwick (B)

Liverpool Clinical Trials Centre, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK.

Dannii Clayton (D)

Liverpool Clinical Trials Centre, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK.

Rhiannon Tudor Edwards (RT)

Centre for Health Economics & Medicines Evaluation, Bangor University College of Human Sciences, Bangor, Gwynedd, UK.

Joanna Mary Charles (JM)

Centre for Health Economics & Medicines Evaluation, Bangor University College of Human Sciences, Bangor, Gwynedd, UK.

Phillipa Logan (P)

Division of Rehabilitation and Ageing, University of Nottingham Faculty of Medicine and Health Sciences, Nottingham, UK.

Monica Busse (M)

Centre for Trials Research, Cardiff University, Cardiff, UK.

Ruth Lewis (R)

North Wales Centre for Primary Care Research, Bangor University College of Human Sciences, Bangor, Gwynedd, UK.

Toby O Smith (TO)

School of Health Sciences, University of East Anglia Faculty of Medicine and Health Sciences, Norwich, Norfolk, UK.

Catherine Sackley (C)

University of Nottingham Faculty of Medicine and Health Sciences, Nottingham, UK.

Val Morrison (V)

School of Psychology, Bangor University College of Human Sciences, Bangor, Gwynedd, UK.

Andrew Lemmey (A)

School of Sports, Health and Exercise Science, Bangor University College of Human Sciences, Bangor, Gwynedd, UK.

Patricia Masterson-Algar (P)

School of Healthcare Sciences, Bangor University College of Human Sciences, Bangor, Gwynedd, UK.

Lola Howard (L)

Liverpool Clinical Trials Centre, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK.

Sophie Hennessy (S)

Liverpool Clinical Trials Centre, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK.

Claire Soady (C)

Liverpool Clinical Trials Centre, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK.

Penelope Ralph (P)

Department of Primary Care and Mental Health, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK.

Susan Dobson (S)

Department of Primary Care and Mental Health, University of Liverpool Faculty of Health and Life Sciences, Liverpool, UK.

Shanaz Dorkenoo (S)

Involving People Network, Health and Care Research Wales, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH